Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA strand crosslinking refers to the formation of covalent bonds between two nucleotides within DNA, either on the same strand (intrastrand) or between opposite strands (interstrand). These crosslinks can be induced by various exogenous agents or endogenous processes. Interstrand crosslinks (ICLs) are particularly cytotoxic as they block essential processes like replication and transcription. Many anticancer drugs function by inducing DNA crosslinks to kill rapidly dividing cells. Defects in pathways repairing interstrand crosslinks cause hypersensitivity to these lesions and underlie genetic disorders such as Fanconi anemia.
Formation of covalent linkages within or between DNA strands, leading to replication and transcription stalling, and ultimately cell death if unrepaired.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Strand Crosslinking.